Navigation Links
Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2013 Year End Financial Information
Date:10/29/2013

ALISO VIEJO, Calif., Oct. 29, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced preliminary financial information (unaudited) for the year ended September 30, 2013, in anticipation of the company's Investor Relations Day in New York City.

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

Based on preliminary financial information for the fiscal year-ended September 30, 2013, Avanir estimates:

  • Total gross revenues of approximately $95.9 million (Non-GAAP)
  • Total net revenues in the range of approximately $75.3 million to $76.3 million
  • Total operating expenses of approximately $116.0 million, excluding cost of product sales of approximately $4.0 million, non-cash items such as share-based compensation of approximately $5.8 million, and depreciation and amortization of long-lived assets of approximately $800,000 and the one-time upfront payment to OptiNose of $20.0 million (Non-GAAP)
  • Cash, cash equivalents and investments in securities totaling approximately $57.5 million, including cash and cash equivalents of approximately $55.3 million and restricted investments in securities of approximately $2.2 million

"We are delighted with the progress of our NUEDEXTA PBA commercial business this year," said Keith Katkin, president and CEO of Avanir. "In addition, the R&D team has made great progress with our pipeline. We now have three active phase II studies of AVP-923 including MS neuropathic pain, Alzheimer's agitation, and the recently announced levodopa-induced dyskinesias in Parkinson's disease.  We continue to expect top-line data from our PRIME study in MS neuropathic pain
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Avanir Pharmaceuticals to Host Investor Day on October 29, 2013
2. Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinsons Disease
3. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
4. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
5. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
6. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
7. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
8. Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck
9. Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
10. Avanir Pharmaceuticals to Participate in Two Conferences in August
11. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Unichem Pharmaceuticals ( ... one lot of Hydrochlorothiazide tablets 25 mg 1000-count bottle ... as a precautionary measure due to the identification of ... product. The risk associated with mistakenly ... is the increased probability of experiencing Clopidogrel,s side effects ...
(Date:7/30/2015)... 30, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... specializes in the patented biopharmaceutical, modernized traditional Chinese medicine ... updates regarding the notice it received on May 21, ... that the Company was below certain of the Exchange,s ... and 1101 of the NYSE MKT Company Guide, due ...
(Date:7/30/2015)... July 30, 2015 ... report with market overview, trends, DRO analysis, ... analysis, recent developments, competitive scenario and top ... Insight: Biosensors Market Development and Demand Forecast ... http://photos.prnewswire.com/prnh/20150727/756778 ) Explore more about ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5
... Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced ... (MAA) with the European Medicines Agency (EMA) for lorcaserin, ... weight loss and maintenance of weight loss, in patients ... overweight (BMI >27) and have at least one weight-related ...
... Corporation (NASDAQ: IRIX ) today announced that ... conferences this month. The Company presents today ... Conference where President and CEO Dominik Beck will host ... the day.  The Company is also ...
Cached Medicine Technology:Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control 2Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control 3Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control 4
(Date:7/31/2015)... ... ... According to WFLA on July 16th, Sarasota has seen at least ... deaths have held steady over the last “couple of months” according to WFLA. Law ... spurred by the crackdown of prescription painkillers. Many users who were addicted to prescription ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... Practice, and Hospital Medicine Practice, is pleased to announce that it has partnered ... application format available on iPhones, iPads, and Android smartphones and tablets. , ...
(Date:7/31/2015)... ... 2015 , ... An article entitled " Dentists Doing Dermatology? ... unfortunate experience having cosmetic skin procedures done by a family doctor not board-certified ... bruising, and pain. This woman’s experience is only one in a series of ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... of a wide variety of nutritional and wellness products, announced the addition of ... specializes in massage therapy, active isolated stretching and the prevention and rehabilitation of ...
(Date:7/31/2015)... ... 31, 2015 , ... People love to feel like they ... price is an important factor to clients when choosing to purchase a policy. ... Preferred Producer Multi-Life Discount program, where advisers pass savings onto their clients. , ...
Breaking Medicine News(10 mins):Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 3Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2
... fear and anxiety are involved, and the amygdalathe brain,s almond-shaped ... But the amygdala doesn,t do its job alone. Scientists at ... the fear map to part of the brain known as ... MD, PhD, found that mice lacking a critical growth factor ...
... scientists at Carnegie Mellon University,s Language Technologies Institute (LTI) ... on Haitian Creole so that translation tools desperately needed ... earthquake-ravaged island can be rapidly developed. Since Carnegie Mellon ... a team at Microsoft Research has used it to ...
... ... ... HealthWorks Medical Group, a leading nationwide operator of on-the-job-injury health and urgent care centers, today ... by getting workers vaccinated against H1N1., , , , ,“U.S. HealthWorks wants to send our ...
... mice ,rejuvenated, when treated with blood factors from younger mice, ... have found a way to make old stem cells in ... could lead to ways to slow the aging process. , ... putting them in old mice made old stem cells take ...
... stem cell therapy, but much research remains to be ... at Stanford University have succeeded in creating brain nerve ... tails of adult mice. , The new approach could ... how cells choose and maintain their specialized roles in ...
... ... Vice Chairwoman, Stephanie DeKemper takes ownership. , ... Indianapolis, IN (PRWEB) Jan. 27, 2010 -- SynCare, LLC ( www.syncarellc.com ) announced ... of Directors Vice Chairwoman Stephanie DeKemper. , , , , ,An aggressive and well-respected consumer ...
Cached Medicine News:Health News:Brain scientists extend map of fear memory formation 2Health News:Carnegie Mellon releases data on Haitian Creole to hasten development of translation tools 2Health News:Twitter Contest: Free, Onsite H1N1 Vaccination Day for Winning Businesses 2Health News:Aging of Blood Stem Cells May Be Reversible 2Health News:Scientists Turn Mouse Skin Cells Into Nerve Cells 2Health News:Scientists Turn Mouse Skin Cells Into Nerve Cells 3Health News:SynCare, LLC Completes Sale of Assets to Stephanie DeKemper 2Health News:SynCare, LLC Completes Sale of Assets to Stephanie DeKemper 3
... Microalbumin Strips provide albumin, creatinine and albumin-to-creatinine ... Microalbumin product is useful to test for ... in order to detect early kidney disease. ... the urinary albumin excretion rate, is an ...
... to near-patient urinalysis. The Chemstrip ... affordable, reliable alternative to visual ... fundamental, easy-to-use features, the Chemstrip ... office lab, clinic, and hospital ...
... UA is the first hand-held urine ... valuable lab bench space. Automation of ... in results between operators and transcription ... run, corrects for ambient temperature and ...
... first outside-the-balloon, dual-wire dilatation catheter. The ... innovative new approach to dilatation. Its unique, ... wires to create expansion planes at low ... ,The FX miniRAIL RX PTCA Catheter is ...
Medicine Products: